Agenus reported $-66395000 in Operating Profit for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbvie ABBV:US $ 4441M 338M
Acceleron Pharma XLRN:US $ -63.66M 0.06M
Agenus AGEN:US $ -66.4M 25.02M
Amgen AMGN:US $ 828M 1301M
AstraZeneca AZN:LN 1.13B 768M
Bristol Myers Squibb BMY:US $ 1715M 36M
Celldex Therapeutics CLDX:US $ -13.44M 3.2M
Chemocentryx CCXI:US $ -38.74M 9.41M
CSL CSL:AU $ 772.1M 1.59B
Dicerna Pharmaceuticals DRNA:US $ -40.24M 11.14M
Dynavax Technologies DVAX:US $ 3.94M 24.59M
Eli Lilly And LLY:US $ 1403.4M 248.1M
Flexion Therapeutics FLXN:US $ -16882000 6.26M
Genocea Biosciences GNCA:US $ -14.55M 2.12M
Gilead Sciences GILD:US $ 2246M 644M
Glaxosmithkline GSK:US $ 1675M 18M
GlaxoSmithKline GSK:LN 1.68B 18M
Immunogen IMGN:US $ -27.37M 1.55M
Intrexon XON:US $ -15.67M 2.01M
Jiangsu Hengrui Me. 600276:CH CH 1.85B 419.35M
Johnson & Johnson JNJ:US $ 3849M 2813M
Karyopharm Therapeutics KPTI:US $ -49048000 3.32M
Macrogenics MGNX:US $ -40279000 11.01M
Merck MRK:GR € 1049M 6M
Merk MRK:US $ 1497M 1517M
Northwest Biotherapeutics NWBO:US -12543000 7.03M
Novartis NOVN:VX 3.48B 1.06B
Novavax NVAX:US $ -345.83M 137.2M
Pfizer PFE:US $ 5914M 397M
Regeneron Pharmaceuticals REGN:US $ 3347.2M 2234.5M
Rigel Pharmaceuticals RIGL:US $ -13.05M 54.8M
Sangamo Biosciences SGMO:US $ -48.7M 2.4M
Veracyte VCYT:US $ -7.47M 37.94M
YTE INCY:US $ 140.84M 42.04M